4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001062993-25-004817
Chief Commercial Officer, MRD sold 26,023 shares at $6.98 ($181,641)
- Chief Commercial Officer, MRD acquired 119,971 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
BOBULSKY SUSAN · Chief Commercial Officer, MRD
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-04 | Grant or award : show line 1 in the form | +119,971 | 373,261 | D | ||
| 2025-03-05 | Sale : show line 2 in the form | −26,023 | $6.98 | $181,641 | 347,238 | D |
| Open-market sales · 26,023 sh · avg $6.98 · $181,641 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-04 | Grant or award : show line 3 in the form Stock Option (right to buy) | +180,029 | 180,029 | D |
Loading xslF345X05/form4.xml…